title: A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print]).
authors.affiliation: Department of Psychiatry, University of British Columbia, 11th Floor, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada, alexander.mcgirr@alumni.ubc.ca.
authors.forename: Alexander
authors.initials: A
authors.lastname: McGirr
authors.forename: Marcelo T
authors.initials: MT
authors.lastname: Berlim
mesh_terms: D000778:Anesthetics, Dissociative / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D061218:Depressive Disorder, Treatment-Resistant / Q000628:therapy*; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*
chemical_list: D000778:Anesthetics, Dissociative; D000928:Antidepressive Agents; D007649:Ketamine